Cargando…
The histone methyltransferase DOT1L is a new epigenetic regulator of pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease with increasing occurrence, high death rates, and unfavorable treatment regimens. The pathogenesis underlying IPF is complex and the epigenetic contributions to IPF are largely unknown. Recent studies have shown that DOT1...
Autores principales: | Yang, Di, Xu, Peng, Su, Haibi, Zhong, Wen, Xu, Jie, Su, Zhenghua, Liu, Xinhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763868/ https://www.ncbi.nlm.nih.gov/pubmed/35039472 http://dx.doi.org/10.1038/s41419-021-04365-5 |
Ejemplares similares
-
Correction: The histone methyltransferase DOT1L is a new epigenetic regulator of pulmonary fibrosis
por: Yang, Di, et al.
Publicado: (2022) -
Inhibition of the cardiac fibroblast-enriched histone methyltransferase Dot1L prevents cardiac fibrosis and cardiac dysfunction
por: Xu, Jie, et al.
Publicado: (2022) -
Histone Methyltransferase Dot1L Contributes to RIPK1 Kinase‐Dependent Apoptosis in Cerebral Ischemia/Reperfusion
por: Wang, Jinghuan, et al.
Publicado: (2021) -
Histone methyltransferase Smyd2 contributes to blood‐brain barrier breakdown in stroke
por: Wang, Jinghuan, et al.
Publicado: (2022) -
Histone methyltransferase Smyd2 drives adipogenesis via regulating STAT3 phosphorylation
por: Su, Haibi, et al.
Publicado: (2022)